从信号通路到向治疗:揭开质母细胞瘤的秘密,利用二十年的进步
Brittany Dewdney1,2, Misty R Jenkins3,4, Sarah A Best4,5
1Cancer Centre, Telethon Kids Institute, Nedlands, WA, 6009, Australia. brittany.dewdney@telethonkids.org.au.
Signal transduction and targeted therapy
|October 19, 2023
概括
质母细胞瘤治疗面临的挑战是由于治疗耐药性和生存率差. 针对性治疗和免疫疗法等新策略显示出改善这种致命脑癌的结果的希望.
科学领域:
- 神经瘤学神经瘤学
- 癌症生物学 癌症生物学
- 翻译医学是一种翻译医学.
背景情况:
- 质母细胞瘤是一种侵袭性脑癌,预后不佳,成人和儿童的治疗耐药性高.
- 尽管技术进步,但将质母细胞瘤病原体的洞察力转化为改善临床结果仍然是一个重大挑战.
研究的目的:
- 审查受体氨酸激酶信号传导,表观遗传机制和质母细胞瘤代谢功能的作用.
- 讨论针对性疗法和新兴方法,如抗体-毒素结合物和质母细胞瘤的CAR T细胞疗法.
- 突出结合策略的潜力,并了解细胞起源在质母细胞瘤的精密医学.
主要方法:
- 文献综述侧重于受体氨酸激酶信号通路.
- 对质母细胞瘤表观遗传机制和代谢功能的分析.
- 检查向疗法,抗体-毒素合物和CAR T细胞疗法.
主要成果:
- 受体氨酸激酶信号传递,表观遗传变化和代谢失调是质母细胞瘤的关键驱动因素.
- 针对性疗法已被广泛探索,在抗体-毒素合物和CAR T细胞疗法中出现了潜在的潜力.
- 结合策略和了解细胞起源对于推进质母细胞瘤治疗至关重要.
结论:
- 质母细胞瘤的发病包括复杂的信号,表观遗传和代谢途径,有助于治疗耐药性.
- 新的治疗策略,包括向药物和免疫疗法,为治疗提供了新的途径.
- 精准医学方法,通过细胞起源的洞察力得到信息,对于改善质母细胞瘤患者的治疗结果至关重要.
相关概念视频
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Amplifying Signals via Enzymatic Cascade
8.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
Notch Signaling Pathway
4.3K
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.3K


